做了12-17歲的三期,效果不錯。就等批了

來源: fuz 2022-05-02 11:51:54 [] [博客] [舊帖] [給我悄悄話] 本文已被閱讀: 次 (2421 bytes)
本文內容已被 [ fuz ] 在 2022-05-02 11:53:54 編輯過。如有問題,請報告版主或論壇管理刪除.

https://www.contemporarypediatrics.com/view/novavax-pediatric-covid-19-vaccine-trial-yields-positive-results

Novavax has announced positive results of their phase 3 PREVENT-19 clinical trial (NCT04511802) evaluating the company’s recombinant nanoparticle protein-based COVID-19 vaccine, NVX-CoV2373.1

The vaccine both achieved the primary effectiveness endpoint—neutralizing antibody responses noninfoerior to those seen in young adult participants of PREVENT-19—and demonstrated an 80% overall efficacy when the Delta SARS-CoV-2 variant was predominant.

The pediatric expansion of the PREVENT-19 trial enrolled 2247 adolescents aged 12 to 17 years across 73 sites in the United States. Trial investigators emphasized the importance of ensuring “well balanced racial and ethnic representation among participants.”

 

請您先登陸,再發跟帖!

發現Adblock插件

如要繼續瀏覽
請支持本站 請務必在本站關閉/移除任何Adblock

關閉Adblock後 請點擊

請參考如何關閉Adblock/Adblock plus

安裝Adblock plus用戶請點擊瀏覽器圖標
選擇“Disable on www.wenxuecity.com”

安裝Adblock用戶請點擊圖標
選擇“don't run on pages on this domain”